• No results found

UVEAL MELONOMA: CURRENT AND EMERGING TREATMENT OPTIONS

N/A
N/A
Protected

Academic year: 2020

Share "UVEAL MELONOMA: CURRENT AND EMERGING TREATMENT OPTIONS"

Copied!
14
0
0

Loading.... (view fulltext now)

Full text

References

Related documents

Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC

The current standard of treatment of bleeding episodes in patients with GT is the use of local measures alone or in conjunction with anti-fibrinolytic therapy first, followed by

Results of the PERSIST-1 Phase III study of pacritinib (PAC) versus best available therapy (BAT) in primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis

A multinational randomized double-blind, placebo-controlled Phase III study named Aflibercept Versus Placebo With FOLFIRI in Patients With Metastatic CRC Previously Treated With

The basic assumption for this mode of therapy is that topical steroids are absorbed in the esophageal mucosa and help to resolve the inflammation and to decrease

Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective

Liver transplantation is the standard therapy for patients who are in a clinical condition good enough to tolerate this intervention because it stops progres- sion of neuropathy

Findings: Patients with chronic migraine require prophylactic therapy to reduce the frequency of migraine attacks, but the only currently available evidence-based prophylactic